ELV - Elevance Health Inc.
Besides Wall Street's top-and-bottom-line estimates for Elevance Health (ELV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2026.
Can ELV overcome a 4.9% premium decline and weaker Health Benefits income? Membership losses add pressure, though higher product revenues may offer some relief.
Elevance Health (NYSE: ELV - Get Free Report) and biote (NASDAQ: BTMD - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership. Analyst Recommendations This is a breakdown of current ratings
Nutex Health and Elevance Health may be underpriced, despite their share growth this year.
Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that its affiliated health plans will offer 2027 Medicare Advantage plans designed to help members navigate healthcare more confidently through meaningful choice, simpler benefit experiences and personalized support that reflects individual health needs. As members evaluate Medicare coverage for 2027, many want to understand their benefits, connect to care, manage healthcare costs and know where to turn for support throu.
Elevance Health (NYSE: ELV - Get Free Report) issued an update on its FY 2026 earnings guidance on Saturday morning. The company provided earnings per share (EPS) guidance of 27.000- for the period, compared to the consensus EPS estimate of 27.160. The company issued revenue guidance of -. Analysts Set New Price Targets A number of
Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.
Corient Private Wealth LP reduced its holdings in shares of Elevance Health, Inc. (NYSE: ELV) by 41.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 41,278 shares of the company's stock after selling 28,940 shares during the period.
Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?
Elevance Health Inc. (NYSE:ELV) shares are jumping Thursday after the company reaffirmed its full-year 2026 earnings guidance ahead of a series of investor meetings. Here's what you should know.
California State Teachers Retirement System boosted its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 37,390.0% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The firm owned 124,019,670 shares of the company's stock after buying an additional 123,688,863 shares during the quarter. California
Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.
Allen Mooney and Barnes Investment Advisors LLC cut its stake in Elevance Health, Inc. (NYSE: ELV) by 6.5% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 46,398 shares of the company's stock after selling 3,218 shares during the quarter.
Beaconlight Capital LLC bought a new position in shares of Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund bought 5,946 shares of the company's stock, valued at approximately $2,299,000. Elevance Health makes up about 0.8% of Beaconlight Capital LLC's
UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.
On August 25, 2026, we delve into the DCF analysis for Elevance Health Inc (ELV), a company that has shown impressive price performance recently, with a year-to
Barrow Hanley Mewhinney and Strauss LLC purchased a new stake in shares of Elevance Health, Inc. (NYSE: ELV) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 452,636 shares of the company's stock, valued at approximately $175,048,000. Barrow Hanley Mewhinney and
B. Metzler seel. Sohn and Co. AG purchased a new position in Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 31,408 shares of the company's stock, valued at approximately $12,146,000. Other institutional investors have also